Table 2.
The baseline patients’ characteristics.
| Number | Control (n = 10) | KAATSU RT (n = 11) | p value | Cohen’s d |
|---|---|---|---|---|
| Male: Female | 9: 1 | 9: 2 | ||
| Age, year | 66 ± 8.7 | 57 ± 12.2 | 0.08 | 0.82 |
| Body mass, kg | 62.7 ± 8.3 | 61.5 ± 9.4 | 0.80 | 0.11 |
| BMI, kg/m2 | 23.1 ± 2.3 | 22.1 ± 3.6 | 0.45 | 0.31 |
| Height, cm | 165.2 ± 7.4 | 167 ± 12 | 0.34 | 0.19 |
| Risk factors, number | ||||
| Hypertension | 7 | 8 | 0.63 | |
| Diabetes | 4 | 3 | 0.44 | |
| Dyslipidemia | 2 | 0 | 0.21 | |
| Smoking | 1 | 1 | 0.74 | |
| Hemodialysis | 0 | 0 | ||
| Atrial fibrillation | 4 | 4 | 0.61 | |
| NYHA I–IV, number | I: 0 | I: 0 | ||
| II: 9 | II: 9 | 0.54 | ||
| III: 1 | III: 2 | 0.54 | ||
| IV: 0 | IV: 0 | |||
| Disease, number | Severe AS: 4 | Severe AS: 3 | 0.44 | |
| Severe AR: 1 | Severe AR: 4 | 0.18 | ||
| Severe MS: 1 | Severe MS: 1 | 0.74 | ||
| Severe MR: 3 | Severe MR: 3 | 0.63 | ||
| A P: 1 | ||||
| Cardiovascular surgery, number | AVR: 5 | AVR: 6 | 0.59 | |
| MVR: 1 | MVR: 1 | 0.74 | ||
| MVP: 3 | MVP: 3 | 0.63 | ||
| other | CABG: 1 | Bentall: 1 | ||
| Creatinine, mg/dL | 0.94 ± 0.2 | 1.06 ± 0.24 | 0.25 | 0.54 |
| Hb, g/dL | 13.6 ± 1.5 | 13.1 ± 2.0 | 0.51 | 0.31 |
| Alb, g/dL | 4.2 ± 0.2 | 3.9 ± 0.6 | 0.06 | 0.89 |
| HbA1c, % | 6.0 ± 0.4 | 5.8 ± 0.6 | 0.33 | 0.44 |
| BNP, pg/ml | 172 ± 138 | 303 ± 262 | 0.14 | 0.69 |
| EF, % | 59 ± 11 | 54 ± 16 | 0.31 | 0.45 |
The mean ± SD values are shown. BW, body mass; BMI, body mass index; NYHA, New York Heart Association; AS, aortic stenosis; AR, aortic regurgitation; MS, mitral stenosis; MR, mitral regurgitation; AP, angina pectoris; AVR, aortic valve replacement; MVR, mitral valve replacement; MVP, mitral valve plasty; CABG, coronary artery bypass grafting; Bentall, Bentall procedure; Hb, hemoglobin; Alb, albumin; HbA1c, hemoglobin A1c; BNP, Brain Natriuretic Peptide; EF, ejection fraction.